Literature DB >> 7585627

Expression of Fas/APO-1 during the progression of astrocytomas.

O Tachibana1, H Nakazawa, J Lampe, K Watanabe, P Kleihues, H Ohgaki.   

Abstract

Fas/APO-1 (CD95) is an apoptosis-signaling receptor molecule on the surface of cells. To investigate the possible role of Fas during malignant transformation of glial cells, we analyzed the expression of Fas mRNA by reverse transcription-PCR in human astrocytic brain tumors. Expression was found in 1 of 4 (25%) juvenile pilocytic astrocytomas (WHO grade I), 1 of 9 (11%) low-grade astrocytomas (WHO grade II), 6 of 12 (50%) anaplastic astrocytomas (WHO grade III), and all of 9 glioblastomas (WHO grade IV). Thus, the frequency of Fas expression appears to correlate with the malignancy grade of astrocytomas. The soluble form of the Fas mRNA lacking the transmembrane domain was detected in one anaplastic astrocytoma and in two glioblastomas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585627

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  In vitro induction of activation-induced cell death in lymphocytes from chronic periodontal lesions by exogenous Fas ligand.

Authors:  T Sawa; F Nishimura; H Ohyama; K Takahashi; S Takashiba; Y Murayama
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Tat protein induces self-perpetuating permissivity for productive HIV-1 infection.

Authors:  C J Li; Y Ueda; B Shi; L Borodyansky; L Huang; Y Z Li; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 3.  The Fas counterattack: a molecular mechanism of tumor immune privilege.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

4.  Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.

Authors:  B Frankel; S L Longo; T C Ryken
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

5.  Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation.

Authors:  S Weisberg; E Ashkenazi; Z Israel; M Attia; Y Shoshan; F Umansky; C Brodie
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Apoptosis and survival in high-grade astrocytomas as related to tumor Fas (APO-1/CD95) expression.

Authors:  Bruce Frankel; Sharon L Longo; Christopher Leach; Gregory W Canute; Timothy C Ryken
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

7.  Protein expression of Fas, Fas ligand, Bcl-2 and TGFbeta2 and correlation with survival in initial and recurrent human gliomas.

Authors:  Rainer J Strege; Christian Godt; Andreas M Stark; Heinz-Hermann Hugo; H Maximilian Mehdorn
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

8.  FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.

Authors:  Ivy A Ho; Wai H Ng; Paula Y Lam
Journal:  Mol Cancer       Date:  2010-10-13       Impact factor: 27.401

9.  Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity.

Authors:  Marianela Candolfi; Kader Yagiz; David Foulad; Gabrielle E Alzadeh; Matthew Tesarfreund; A K M Ghulam Muhammad; Mariana Puntel; Kurt M Kroeger; Chunyan Liu; Sharon Lee; James F Curtin; Gwendalyn D King; Jonathan Lerner; Katsuaki Sato; Yohei Mineharu; Weidong Xiong; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2009-07-01       Impact factor: 12.531

10.  Clinical and oncological significance of aberrant Fas (APO-1/CD95) isoform expression in adult T-cell leukemia.

Authors:  S Kamihira; Y Yamada; T Maeda
Journal:  Indian J Clin Biochem       Date:  2000-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.